Education
About Us
Working with TipRanks
Follow Us
BioCorRx Inc (BICX)
OTHER OTC:BICX
BICX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.20 - $1.45
Previous CloseN/A
Volume44.00
Average Volume (3M)484.00
Market Cap
$6.46M
Enterprise Value$9.18M
Total Cash (Recent Filing)$24.14K
Total Debt (Recent Filing)$2.74M
Price to Earnings (P/E)―
Beta0.41
Next Earnings
May 20, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.14
Shares Outstanding16,996,851
10 Day Avg. Volume639
30 Day Avg. Volume484
Financial Highlights & Ratios
PEG Ratio-0.08
Price to Book (P/B)-0.49
Price to Sales (P/S)0.00
P/FCF Ratio-4.47
Enterprise Value/Market Cap1.42
Enterprise Value/Revenue27.43
Enterprise Value/Gross Profit55.20
Enterprise Value/Ebitda-0.65
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
BioCorRx News
PremiumCompany Announcements
BioCorRx Inc Board Sees Dual Director ResignationsOptions Prices
Currently, No data available
---
Ownership Overview
20.12% Insiders
―
Mutual Funds
― Other Institutional Investors
79.88% Public Companies and
Individual Investors
BICX FAQ
What was BioCorRx Inc’s price range in the past 12 months?
BioCorRx Inc lowest stock price was $0.20 and its highest was $1.45 in the past 12 months.
What is BioCorRx Inc’s market cap?
BioCorRx Inc’s market cap is $6.46M.
When is BioCorRx Inc’s upcoming earnings report date?
BioCorRx Inc’s upcoming earnings report date is May 20, 2025 which is 59 days ago.
How were BioCorRx Inc’s earnings last quarter?
Currently, no data Available
Is BioCorRx Inc overvalued?
According to Wall Street analysts BioCorRx Inc’s price is currently Overvalued.
Does BioCorRx Inc pay dividends?
BioCorRx Inc does not currently pay dividends.
What is BioCorRx Inc’s EPS estimate?
BioCorRx Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BioCorRx Inc have?
BioCorRx Inc has 16,996,851 shares outstanding.
What happened to BioCorRx Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of BioCorRx Inc?
Currently, no hedge funds are holding shares in BICX
Company Description
BioCorRx Inc
BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.
Technical Analysis
Kazia Therapeutics
―
Creative Medical Technology Holdings
―
Silo Pharma
―
Aditxt
―
Galecto
―